Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-13 5:36 pm Purchase |
2024-09-30 | 13G | Aytu BioPharma, Inc. AYTU |
Stonepine Capital Management, LLC | 626,862 9.990% |
61,378 (+10.85%) |
Filing History |
| 2024-06-18 4:30 pm Unchanged |
2024-06-14 | 13D | Aytu BioPharma, Inc. AYTU |
Nantahala Capital Management, LLC | 1,086,812 18.200% |
0 (Unchanged) |
Filing History |
| 2024-02-13 4:25 pm Purchase |
2023-12-31 | 13G | Aytu BioPharma, Inc. AYTU |
Stonepine Capital Management, LLC | 565,484 9.990% |
1,642 (+0.29%) |
Filing History |
| 2023-06-16 5:14 pm Purchase |
2023-06-13 | 13D | Aytu BioPharma, Inc. AYTU |
Nantahala Capital Management, LLC | 1,086,812 19.700% |
815,217 (+300.16%) |
Filing History |
| 2023-06-16 4:48 pm Purchase |
2023-06-09 | 13G | Aytu BioPharma, Inc. AYTU |
Stonepine Capital Management, LLC | 563,842 9.990% |
563,842 (New Position) |
Filing History |
| 2023-05-26 1:52 pm Purchase |
2023-05-26 | 13D | Aytu BioPharma, Inc. AYTU |
Nantahala Capital Management, LLC | 271,595 7.200% |
271,595 (New Position) |
Filing History |
| 2023-02-14 11:23 am Purchase |
2022-12-31 | 13G | Aytu BioPharma, Inc. AYTU |
CVI Investments, Inc. | 3,278,844 4.900% |
3,278,844 (New Position) |
Filing History |
| 2022-08-15 10:01 am Purchase |
2022-08-10 | 13G | Aytu BioPharma, Inc. AYTU |
CVI Investments, Inc. | 68,000,000 5.600% |
68,000,000 (New Position) |
Filing History |
| 2022-02-11 3:29 pm Sale |
2021-12-31 | 13G | Aytu BioPharma, Inc. AYTU |
Stonepine Capital Management, LLC | 0 0.000% |
-27,975,520 (Position Closed) |
Filing History |
| 2021-09-01 4:25 pm Purchase |
2021-09-01 | 13D | Aytu BioPharma, Inc. AYTU |
Armistice Capital, LLC | 27,530,900 4.900% |
683,340 (+2.55%) |
Filing History |
| 2021-08-31 4:32 pm Purchase |
2021-08-30 | 13D | Aytu BioPharma, Inc. AYTU |
Armistice Capital, LLC | 26,847,560 5.300% |
26,847,560 (New Position) |
Filing History |
| 2021-03-26 4:21 pm Purchase |
2021-03-18 | 13G | Aytu BioPharma, Inc. AYTU |
Integrated Core Strategies (US) LLC | 457,320 0.100% |
457,320 (New Position) |
Filing History |
| 2021-02-12 4:57 pm Purchase |
2020-12-31 | 13G | Aytu BioPharma, Inc. AYTU |
Stonepine Capital Management, LLC | 27,975,520 8.100% |
1,308,840 (+4.91%) |
Filing History |
| 2021-02-10 10:45 am Unchanged |
2020-12-31 | 13G | Aytu BioPharma, Inc. AYTU |
Altium Capital Management LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2021-01-05 11:45 am Purchase |
2020-12-31 | 13G | Aytu BioPharma, Inc. AYTU |
SABBY MANAGEMENT LLC | 14,614,140 11.000% |
14,614,140 (New Position) |
Filing History |
| 2020-12-21 5:07 pm Purchase |
2020-12-11 | 13D | Aytu BioPharma, Inc. AYTU |
Armistice Capital, LLC | 26,666,680 7.700% |
25,851,934 (+3173.01%) |
Filing History |
| 2020-12-16 6:02 pm Purchase |
2020-12-11 | 13G | Aytu BioPharma, Inc. AYTU |
Stonepine Capital Management, LLC | 26,666,680 7.700% |
26,666,680 (New Position) |
Filing History |
| 2020-04-29 5:29 pm Sale |
2020-04-27 | 13D | Aytu BioPharma, Inc. AYTU |
Armistice Capital, LLC | 814,746 0.400% |
-9,403,096 (-92.03%) |
Filing History |
| 2020-04-27 4:30 pm Unchanged |
2020-04-10 | 13G | Aytu BioPharma, Inc. AYTU |
Avalo Therapeutics Inc. AVTX |
0 0.000% |
0 (Unchanged) |
Filing History |